Roger W. Brimblecombe, Ph.D.

Besides Dr. Boger, Dr. Brimblecombe is the longest active serving member of Vertex’s board, which he joined in 1993.

Dr. Brimblecombe served as Chairman of Vanguard Medica Ltd. from 1991 to 2000, as Chairman of Core Group plc from 1997 to 1999, Oxford Asymmetry International plc from 1997 to 2000 and pSivida Ltd from 2002 to 2007. From 1979 to 1990, he held various Vice Presidential posts in SmithKline & French Laboratories' research and development organization. He is a partner in MVM Life Science Partners LLP and a director of Tissue Science Laboratories plc. (listed on the AIM market in the United Kingdom). He holds Ph.D. and D.Sc. degrees in pharmacology from the University of Bristol, England.